Opioid regulation of spinal cord plasticity: Evidence the kappa-2 opioid receptor agonist GR89696 inhibits learning within the rat spinal cord

Neurobiology of Learning and Memory

Volumn 89, Issue 1, 2008, Pages 1-16

  Washburn, Stephanie N ^a   Maultsby, Marissa L ^a   Puga, Denise A ^a   Grau, James W ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

GR89696; Instrumental learning; Opioids; Plasticity; Spinal cord

Indexed keywords

4 [(3,4 DICHLOROPHENYL)ACETYL] 3 (1 PYRROLIDINYLMETHYL) 1 PIPERAZINECARBOXYLIC ACID METHYL ESTER; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA 2 OPIOID RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALTREXONE; OPIATE; OPIATE AGONIST; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; LEARNING; LEARNING DISORDER; MALE; NERVE CELL; NONHUMAN; PLASTICITY; RAT; SPINAL CORD;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ASSOCIATION LEARNING; BENZENEACETAMIDES; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; MALE; NEURONAL PLASTICITY; NEURONS; NEUROTRANSMITTER AGENTS; PIPERAZINES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SPINAL CORD; SPINAL CORD INJURIES; THORACIC VERTEBRAE;

EID: 36049040303     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2007.09.009     Document Type: Article

References (59)

1. Bakshi R., Ni R.X., and Faden A.I. N-methyl-d-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies. Brain Research 580 (1992) 255-264
2. Birch P.J., Rogers H., Hayes A.G., Hayward N.J., Tyers M.B., Scopes D.I., et al. Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist. British Journal of Pharmacology 103 (1991) 1819-1823
3. Butelman E.R., Ko M.C.H., Traynor J.R., Vivian J.A., Kreek M.-J., and Woods J.H. GR89,696: A potent K-opioid agonist with subtype selectivity in rhesus monkeys. Journal of Pharmaoclogy and Experimental Therapeutics 298 (2001) 1049-1059
4. Caudle R.M., Chavkin C., and Dubner R. Kappa 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells. Journal of Neuroscience 14 (1994) 5580-5589
5. Caudle R.M., Finegold A.A., Mannes A.J., Tobias M.D., Kenshalo Jr. D.R., and Iadarola M.J. Spinal kappa1 and kappa2 opioid binding sites in rats, guinea pigs, monkeys and humans. Neuroreport 9 (1998) 2523-2525
6. Caudle R.M., and Mannes A.J. Dynorphin: Friend or foe?. Pain 87 (2000) 235-239
7. Caudle R.M., Mannes A.J., and Iadarola M.J. GR89,696 is a kappa-2 opioid receptor agonist and a kappa-1 opioid receptor antagonist in the guinea pig hippocampus. Journal of Pharmacology and Experimental Therapeutics 283 (1997) 1342-1349
8. Coderre T.J. The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats. Molecular Neurobiology 7 (1993) 229-246
9. Crown E.D., and Grau J.W. Preserving and restoring behavioral potential within the spinal cord using an instrumental training paradigm. Journal of Neurophysiology 86 (2001) 845-855
10. Crown E.D., and Grau J.W. Evidence that descending systems protect behavioral plasticity against the disruptive effect of nociceptive stimulation. Experimental Neurology 196 (2005) 164-176
11. Crown E.D., Joynes R.L., Ferguson A.R., and Grau J.W. Instrumental learning within the spinal cord: IV. Induction and retention of the behavioral deficit observed after noncontingent shock. Behavioral Neuroscience 116 (2002) 1032-1051
12. Dickenson A.H. Balances between excitatory and inhibitory events in the spinal cord and chronic pain. Progress in Brain Research 110 (1996) 225-231
13. Eliav E., Herzberg U., and Caudle R.M. The kappa opioid agonist GR89,696 blocks hyperalgesia and allodynia in rat models of peripheral neuritis and neuropathy. Pain 79 (1999) 255-264
14. Edgerton V.R., Tillakartne N.J., Bigbee A.J., de Leon R.D., and Roy R.R. Plasticity of the spinal neural circuitry after injury. Annual Review of Neuroscience 27 (2004) 145-167
15. Faden A.I. Neurotoxic versus neuroprotective actions of endogenous opioid peptides: Implications for treatment of CNS injury. NIDA Research Monograph 163 (1996) 318-330
16. Faden A.I., and Jacobs T.P. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action. British Journal of Pharmacology 81 (1984) 271-276
17. Ferguson A.R., Washburn S.N., Crown E.R., and Grau J.W. GABA-A receptor activation is involved in non-contingent shock inhibition of instrumental conditioning in spinal rat. Behavioral Neuroscience 117 (2003) 799-812
18. Ferguson A.R., Crown E.D., and Grau J.W. Nociceptive plasticity inhibits adaptive learning in the spinal cord. Neuroscience 141 (2006) 421-431
19. Gallagher M., King R.A., and Young N.B. Opiate antagonists improve spatial memory. Science 221 (1983) 975-976
20. Gouarderes C., Audigier Y., and Cros J. Benzomorphan binding sites in rat lumbo-sacral spinal cord. European Journal of Pharmacology 78 (1982) 483-486
21. Gómez-Pinilla F., Huie J.R., Ying Z., Ferguson A., Crown E.D., Baumbauer K.M., et al. BDNF and learning: Evidence that instrumental training promotes learning within the spinal cord by up-regulating BDNF expression. Neuroscience 148 (2007) 893-906
22. Grau J.W., Barstow D.G., and Joynes R.L. Instrumental learning within the spinal cord: I. Behavioral properties. Behavioral Neuroscience 112 (1998) 1366-1386
23. Grau J.W., Crown E.D., Ferguson A.R., Washburn S.N., Hook M.A., and Miranda R.C. Instrumental learning within the spinal cord: Underlying mechanisms and implications for recovery after injury. Behavioral and Cognitive Neuroscience Reviews 5 (2006) 191-239
24. Grau J.W., Hyson R.L., Maier S.F., Madden J., and Barchas J.D. Long-term stress-induced analgesia and activation of the opiate system. Science 213 (1981) 1409-1411
25. Grau J.W., Washburn S.N., Hook M.A., Ferguson A.R., Crown E.D., Garcia G., Bolding K.A., and Miranda R.C. Uncontrollable nociceptive stimulation undermines recovery after spinal cord injury. Neurotrauma 21 (2004) 1795-1817
26. Ho J., Mannes A.J., Dubner R., and Caudle R.M. Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation. Journal of Pharmacology and Experimental Therapeutics 281 (1997) 136-141
27. Hodgson J.A., Roy R.R., de Leon R., Dobkin B., and Edgerton V.R. Can the mammalian lumbar spinal cord learn a motor task?. Medicine and Science in Sports and Exercise 26 (1994) 1491-1497
28. Hook M.A., and Grau J.W. An animal model of functional electrical stimulation: Evidence that the central nervous system modulates the consequences of training. Spinal Cord (2007)
29. Hook M.A., Huie J.R., and Grau J.W. Peripheral inflammation undermines the plasticity of the isolated spinal cord. Behavioral Neuroscience (2007)
30. Iadarola M.J., Brady L.S., Draisci G., and Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: Stimulus specificity, behavioral parameters and opioid receptor binding. Pain 35 (1988) 313-326
31. Jamot L., Matthes H.W.D., Simonin F., Kieffer B.L., and Roder J.C. Differential involvment of the mu and kappa opioid receptors in spatial learning. Genes, Brain and Behavior 2 (2003) 80-92
32. Ji R.R., Kohno T., Moore K.A., and Woolf C.J. Central sensitization and LTP: Do pain and memory share similar mechanisms?. Trends in Neurosciences 26 (2003) 696-705
33. Joynes R.L., and Grau J.W. Instrumental learning within the spinal cord: III. Prior exposure to noncontingent shock induces a behavioral deficit that is blocked by an opioid antagonist. Neurobiology of Learning and Memory 82 (2004) 35-51
34. Joynes R.L., Janjua K., and Grau J.W. Instrumental learning within the spinal cord: VI. The NMDA receptor antagonist, AP5, disrupts acquisition and maintenance of an acquired flexion response. Behavioural Brain Research 154 (2004) 431-438
35. Lai J., Ossipov M.H., Vanderah T.W., Malan Jr. T.P., and Porreca F. Neuropathic pain: The paradox of dynorphin. Molecular Interventions 1 (2001) 160-167
36. Laughlin T.M., Vanderah T.W., Lashbrook J., Nichols M.L., Ossipov M., Porreca F., et al. Spinally administered dynorphin A produces a long-lasting allodynia: Involvement of NMDA but not opioid receptors. Pain 7 (1997) 253-260
37. Liu G.T., Crown E.D., Miranda R.C., and Grau J.W. Instrumental learning within the rat spinal cord: Localization of the essential neural circuit. Behavioral Neuroscience 119 (2005) 538-547
38. Long J.B., Petras J.M., Mobley W.C., and Holaday J.W. Neurological dysfunction after intrathecal injection of dynorphin A(1-13) in the rat. II. Nonopioid mechanism mediate loss of motor, sensory and autonomic function. Journal of Pharmacology and Experimental Therapeutics 88 (1988) 1167-1174
39. Ma Q.-P., and Woolf C.J. Noxious stimuli induce an N-methyl-d-aspartate receptor-dependent hypersensitivity of the flexion withdrawal reflex to touch: implications for the treatment of mechanical allodynia. Pain 61 (1995) 383-390
40. Malen T.P., Ossipov M.H., Gardell L.R., Ibrahim M., Bian D., Lai J., et al. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injurred rats. Pain 86 (2000) 185-194
41. Moser E.I., Krobert K.A., Moser M.B., and Morris R.G. Impaired spatial learning after saturation of long-term potentiation. Science 281 (1998) 2038-2042
42. Moser E.I., and Moser M.-B. Is learning blocked by saturation of synaptic weights in the hippocampus?. Neuroscience Biobehavioral reviews 23 (1999) 661-672
43. Rusovici D.E., Negus S.S., Mello N.K., and Bidlack J.M. K-Opioid receptors are differentially labeled by arylacetamides and benzomorphans. European Journal of Pharmacology 485 (2004) 119-125
44. Sandin J., Nylander I., Georgieva J., Schott P.A., Ogren S.O., and Terenius L. Hippocampal dynorphin B injections impair spatial learning in rats: A kappa-opioid receptor-mediated effect. Neuroscience 85 (1998) 375-382
45. Sharifi N., Diehl N., Yaswen L., and Brennan M.B. Generation of dynorphin knockout mice. Molecular Brain Research 86 (2001) 70-75
46. Stevens C.W., and Yaksh T.L. Dynorphin A and related peptides administered intrathecally in the rat: A search for putative kappa opiate receptor activity. Journal of Pharmacology and Experimental Therapeutics 238 (1986) 833-838
47. Terman G.W., Drake C.T., Simmons M.L., Milner T.A., and Chavkin C. Opioid modulation of recurrent excitation in the hippocampal dentate gyrus. Journal of Neuroscience 20 (2000) 4379-4388
48. Terman G.W., Wagner J.J., and Chavkin C. Kappa opioids inhibit induction of long-term potentiation in the dentate gyrus of the guinea pig hippocampus. Journal of Neuroscience 14 (1994) 4740-4747
49. Vanderah T.W., Laughlin T., Lashbrook J.M., Nichols M.L., Wilcox G.L., Ossipov M.H., et al. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: Blockade by MK-801 but not naloxone. Pain 68 (1996) 275-281
50. Wagner J.J., Caudle R.M., and Chavkin C. Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus. Journal of Neuroscience 12 (1992) 132-141
51. Wagner J.J., Terman G.W., and Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 363 (1993) 451-454
52. Wang Z., Gardell L.R., Ossipov M.H., Vanderah T.W., Brennan M.B., Hochgeschwender U., et al. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. Journal of Neuroscience 21 (2001) 279-286
53. Wernig A., Muller S., Nanassy A., and Cagol E. Laufband therapy based on 'rules of spinal locomotion' is effective in spinal cord injured persons. European Journal of Neuroscience 7 (1995) 823-829
54. Willis W.D. Mechanisms of central sensitization of nociceptive dorsal horn neurons. In: Patterson M.M., and Grau J.W. (Eds). Spinal cord plasticity: Alterations in reflex function (2001), Kluwer Academic Publishers
55. Willis W.D., Sluka K.A., Rees H., and Westlund K.N. Cooperative mechanisms of neurotransmitter action in central nervous sensitization. Progress in Brain Research 110 (1996) 151-166
56. Wolpaw J.R., and Carp J.S. Memory traces in spinal cord. Trends in Neuroscience 13 (1990) 137-142
57. Woolf C.J., and Thompson S.W.N. The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation: Implications for the treatment of post-injury pain hypersensitivity states. Pain 44 (1991) 293-299
58. Yaksh T.L., and Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiology and Behavior 17 (1976) 1031-1036
59. Zukin, R. S., Eghbali, M., Olive, D., Unterwald, E. M., Tempel, A. (1988). Characterization and visualization of rat and guinea pig brain kappa opioid receptors: Evidence for kappa 1 and kappa 2 opioid receptors. Proceedings of the National Academy of Sciences of the United States of America, 85, 4061-4065.